Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimum Thiamine Intervention (OpT In) for Treatment and Prevention of Wernicke-Korsakoff Syndrome (WKS): A Randomised Controlled Trial

NCT02788552 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT02788552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02788552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimum Thiamine Intervention (OpT In) for Treatment and Prevention of Wernicke-Korsakoff Syndrome (WKS): A Randomised Controlled Trial
Lead sponsor
Menzies School of Health Research
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
August 1, 2019
Enrollment
334 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wernicke-korsakoff syndrome